Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Therapeutics Q4 Operating Expenses USD 55.259 Million

Mar 10 (Reuters) - Cullinan Therapeutics Q4 net income USD -50.713 million.

Q4 operating income USD -55.259 million vs. IBES estimate USD -56.5 million

Q4 pretax profit USD -50.713 million vs. IBES estimate USD -51.5 million

Recent news on Cullinan Therapeutics

See all news